Gene and cell therapy for cystic fibrosis: from bench to bedside

M Conese, F Ascenzioni, AC Boyd, C Coutelle… - Journal of Cystic …, 2011 - Elsevier
Clinical trials in cystic fibrosis (CF) patients established proof-of-principle for transfer of the
wild-type cystic fibrosis transmembrane conductance regulator (CFTR) gene to airway …

In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application

G Almeida-Porada, A Atala, CD Porada - Molecular Therapy-Methods & …, 2016 - cell.com
Recent advances in high-throughput molecular testing have made it possible to diagnose
most genetic disorders relatively early in gestation with minimal risk to the fetus. These …

Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid …

AC Nathwani, C Rosales, J McIntosh, G Rastegarlari… - Molecular therapy, 2011 - cell.com
Adeno-associated virus vectors (AAV) show promise for liver-targeted gene therapy. In this
study, we examined the long-term consequences of a single intravenous administration of a …

Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine …

AC Nathwani, JT Gray, CYC Ng, J Zhou, Y Spence… - Blood, 2006 - ashpublications.org
Transduction with recombinant adeno-associated virus (AAV) vectors is limited by the need
to convert its single-stranded (ss) genome to transcriptionally active double-stranded (ds) …

Rab38 and Rab32 control post-Golgi trafficking of melanogenic enzymes

C Wasmeier, M Romao, L Plowright… - The Journal of cell …, 2006 - rupress.org
Amutation in the small GTPase Rab38 gives rise to the mouse coat color phenotype
“chocolate”(cht), implicating Rab38 in the regulation of melanogenesis. However, its role …

Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes

AL Parker, SN Waddington, CG Nicol… - Blood, 2006 - ashpublications.org
Upon local delivery, adenovirus (Ad) serotype 5 viruses use the coxsackie and Ad receptor
(CAR) for cell binding and αv integrins for internalization. When administered systemically …

Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice

M Themis, SN Waddington, M Schmidt, C Von Kalle… - Molecular Therapy, 2005 - cell.com
Gene therapy by use of integrating vectors carrying therapeutic transgene sequences offers
the potential for a permanent cure of genetic diseases by stable vector insertion into the …

Intravenous administration of AAV2/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system

AA Rahim, AMS Wong, K Hoefer… - The FASEB …, 2011 - Wiley Online Library
Several diseases of the nervous system are characterized by neurodegeneration and death
in childhood. Conventional medicine is ineffective, but fetal or neonatal gene therapy may …

Persistent expression of hF. IX After tolerance induction by in utero or neonatal administration of AAV-1-F. IX in hemophilia B mice

DE Sabatino, TC MacKenzie, W Peranteau… - Molecular Therapy, 2007 - cell.com
The major complication associated with protein replacement therapy currently used in the
treatment of hemophilia B (HB) is the development of antibodies to the infused human Factor …

[HTML][HTML] Gene therapy for hemophilia

GL Rogers, RW Herzog - Frontiers in bioscience (Landmark edition …, 2015 - ncbi.nlm.nih.gov
Hemophilia is an X-linked inherited bleeding disorder consisting of two classifications,
hemophilia A and hemophilia B, depending on the underlying mutation. Although the …